Global Folic Acid Injection Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Folic Acid Injection Market Research Report 2024
Folic Acid Injection is a sterile, nonpyrogenic solution of sodium folate prepared by the addition of sodium hydroxide to folic acid in Water for Injection intended for intramuscular, intravenous or subcutaneous use. Folic acid is a B-complex vitamin needed to form healthy cells, especially red blood cells. Folic acid is used to treat or prevent certain anemias caused by poor diet, pregnancy, alcoholism, liver disease, certain stomach/intestinal problems, kidney dialysis, or other conditions.
According to Mr Accuracy reports’s new survey, global Folic Acid Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Folic Acid Injection market research.
Key manufacturers engaged in the Folic Acid Injection industry include Merck & Co, Eli Lilly, Sandoz Canada Incorporated, Ceva Animal Health Australia, Shanghai Pharmaceuticals and Anhui Medipharm, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Folic Acid Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Folic Acid Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Folic Acid Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Merck & Co
Eli Lilly
Sandoz Canada Incorporated
Ceva Animal Health Australia
Shanghai Pharmaceuticals
Anhui Medipharm
Segment by Type
Folic Acid Inj 5mg/ml
Folic Acid Inj 30mg/2ml
Elderly
Children
Adult
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Folic Acid Injection report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Folic Acid Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Folic Acid Injection market research.
Key manufacturers engaged in the Folic Acid Injection industry include Merck & Co, Eli Lilly, Sandoz Canada Incorporated, Ceva Animal Health Australia, Shanghai Pharmaceuticals and Anhui Medipharm, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Folic Acid Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Folic Acid Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Folic Acid Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck & Co
Eli Lilly
Sandoz Canada Incorporated
Ceva Animal Health Australia
Shanghai Pharmaceuticals
Anhui Medipharm
Segment by Type
Folic Acid Inj 5mg/ml
Folic Acid Inj 30mg/2ml
Segment by Application
Elderly
Children
Adult
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Folic Acid Injection report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices